Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Jane Cullis

ID: 1b83cc83-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

British Columbia Announces Coverage of Three New Biosimilars for Blood Clot Prevention and Treatment

Big Molecule Watch · March 29, 2022

AbbVie Moves to Strike Alvotech’s Final Invalidity and Unenforceability Contentions

Big Molecule Watch · February 24, 2022

Biosimilar Partnership News

Big Molecule Watch · December 14, 2021

Amgen and Pfizer Developing More Interchangeable Biosimilars

Big Molecule Watch · November 10, 2021

Bevacizumab Biosimilar Demonstrates Positive Phase 3 Results for the Treatment of Non-Small Cell Lung Cancer

Big Molecule Watch · October 5, 2021

Previous

12

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog